These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 16896285)

  • 1. Clinical trial design in systemic lupus erythematosus.
    Dall'Era M; Wofsy D
    Curr Opin Rheumatol; 2006 Sep; 18(5):476-80. PubMed ID: 16896285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, quality, and bias in randomized controlled trials of systemic lupus erythematosus.
    Karassa FB; Tatsioni A; Ioannidis JP
    J Rheumatol; 2003 May; 30(5):979-84. PubMed ID: 12734892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains.
    Smolen JS; Strand V; Cardiel M; Edworthy S; Furst D; Gladman D; Gordon C; Isenberg DA; Klippel JH; Petri M; Simon L; Tugwell P; Wolfe F
    J Rheumatol; 1999 Feb; 26(2):504-7. PubMed ID: 9972996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EULAR points to consider for conducting clinical trials in systemic lupus erythematosus.
    Gordon C; Bertsias G; Ioannidis JP; Boletis J; Bombardieri S; Cervera R; Dostál C; Font J; Gilboe IM; Houssiau F; Huizinga TW; Isenberg D; Kallenberg CG; Khamashta MA; Piette JC; Schneider M; Smolen JS; Sturfelt G; Tincani A; Van Vollenhoven R; Boumpas DT
    Ann Rheum Dis; 2009 Apr; 68(4):470-6. PubMed ID: 18388158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring outcomes in systemic lupus erythematosus clinical trials.
    Strand V; Chu AD
    Expert Rev Pharmacoecon Outcomes Res; 2011 Aug; 11(4):455-68. PubMed ID: 21831027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials.
    Yuen SY; Pope JE
    Rheumatology (Oxford); 2008 Sep; 47(9):1367-72. PubMed ID: 18577549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials in systemic lupus erythematosus (SLE): lessons from the past as we proceed to the future--the EULAR recommendations for the management of SLE and the use of end-points in clinical trials.
    Bertsias G; Gordon C; Boumpas DT
    Lupus; 2008 May; 17(5):437-42. PubMed ID: 18490423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of systemic lupus erythematosus.
    O'Neill SG; Schrieber L
    Autoimmun Rev; 2005 Jul; 4(6):395-402. PubMed ID: 16081031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging biological drugs: a new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events.
    Murdaca G; Colombo BM; Puppo F
    Autoimmun Rev; 2011 Nov; 11(1):56-60. PubMed ID: 21835271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study.
    Costenbader KH; Brome D; Blanch D; Gall V; Karlson E; Liang MH
    Arthritis Rheum; 2007 Feb; 57(1):49-55. PubMed ID: 17266094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-evaluation of biologic therapies in systemic lupus erythematosus.
    Bruce IN
    Curr Opin Rheumatol; 2010 May; 22(3):273-7. PubMed ID: 20177385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologics in the treatment of systemic lupus erythematosus.
    Lateef A; Petri M
    Curr Opin Rheumatol; 2010 Sep; 22(5):504-9. PubMed ID: 20502332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial design in systemic lupus erythematosus: lessons learned and future directions.
    Strand V
    Lupus; 2004; 13(5):406-11. PubMed ID: 15230300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of exercise in the rehabilitation of patients with systemic lupus erythematosus and patients with primary Sjögren's syndrome.
    Strömbeck B; Jacobsson LT
    Curr Opin Rheumatol; 2007 Mar; 19(2):197-203. PubMed ID: 17278938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blinding protocols, treatment credibility, and expectancy: methodologic issues in clinical trials of osteopathic manipulative treatment.
    Licciardone JC; Russo DP
    J Am Osteopath Assoc; 2006 Aug; 106(8):457-63. PubMed ID: 16943515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trials in systemic lupus erythematosus: what has been done and what do we need to do?
    Schiffenbauer J; Simon LS
    Lupus; 2004; 13(5):398-405. PubMed ID: 15230299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell-directed therapies in systemic lupus erythematosus.
    Tieng AT; Peeva E
    Semin Arthritis Rheum; 2008 Dec; 38(3):218-27. PubMed ID: 18206214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel therapeutics for systemic lupus erythematosus.
    Wiesendanger M; Stanevsky A; Kovsky S; Diamond B
    Curr Opin Rheumatol; 2006 May; 18(3):227-35. PubMed ID: 16582684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating patient-centered outcomes in the randomized controlled trial and beyond: informing the future with lessons from the past.
    Booth CM
    Clin Cancer Res; 2010 Dec; 16(24):5963-71. PubMed ID: 21169249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of rituximab in patients with systemic lupus erythematosus: an update.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Galarza-Maldonado C; Sandoval-Cruz M; Zamudio-Huerta L; López-Colombo A; Cervera R
    Autoimmun Rev; 2009 Feb; 8(4):343-8. PubMed ID: 19036350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.